journal article·2026-06

A Morphology‐Driven Cascade Delivery of Antigens for Potent T Cell Immunity

Shuting Bai, Yuan Xue, Chunting He, Kun Xiong, Tianyi Luo, Xue Tang, Yanhua Xu, Nan Qiao, Ming Qin, Xiaofang Zhong, Penghui He, Hongjiao Wei, Yangsen Ou, Guangsheng Du, Xun Sun

Advanced Materials· Volume 38· Issue 35
Publisher page

Abstract

ABSTRACT Subunit vaccines are hampered by their inability to elicit robust cellular immunity and cross‐protection. The spatiotemporal fate of vaccine components within the body is key to overcoming this hurdle. Here, we report a cascade “Lymph nodes–Antigen presenting cells–Endoplasmic reticulum (LAE)” delivery strategy enabled by engineering the surface topography of nanoparticles. We designed mesoporous silica nanoparticles with smooth, short‐spiked, and long‐spiked (SNL) morphologies. Among them, SNL showed superior antigen peptide delivery and APC activation. Mechanistically, SNL enhanced Piezo1‐mediated calcium influx through mechanical stimulation, promoting dendritic cell activation and increasing antigen trafficking to the endoplasmic reticulum (ER), a key site for cross‐presentation. Capitalizing on this ER‐targeting capability, we co‐loaded the STING agonist 2′3′‐cGAMP with antigen peptides into SNL, yielding synergistic immune activation. This combination induced potent CD8 + T cell responses, delayed tumor progression in lymphoma and cervical cancer models, and conferred cross‐protective immunity in a SARS‐CoV‐2 vaccination model. Our study establishes nanoparticle morphology as an important design parameter for orchestrating the precise intracellular delivery of vaccine components, offering a generalizable platform for next‐generation vaccines.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Immunotherapy and Immune Responses · interferon and immune responses · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Key Laboratory of Drug‐Targeting and Drug Delivery System of the Education Ministry and Sichuan Province Sichuan Engineering Laboratory For Plant‐Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology West China School of Pharmacy Sichuan University Chengdu P. R. China

Department of Anesthesiology Laboratory of Anesthesia and Critical Care Medicine National‐Local Joint Engineering Research Centre of Translational Medicine of Anesthesiology West China Hospital Sichuan University Chengdu P. R. China

Funding

National Natural Science Foundation of China · Higher Education Discipline Innovation Project · Fundamental Research Funds for the Central Universities

References (59)

Show source-provided references
1. 10.1038/s41573‐024‐01041‐z10.1038/s41573‐024‐01041‐z ↗
2. 10.1038/s41467‐024‐50087‐510.1038/s41467‐024‐50087‐5 ↗
3. 10.1038/s41578‐021‐00372‐210.1038/s41578‐021‐00372‐2 ↗
4. 10.1073/pnas.220784111910.1073/pnas.2207841119 ↗
5. 10.1038/s41591‐023‐02760‐310.1038/s41591‐023‐02760‐3 ↗
6. 10.1038/s41467‐023‐39770‐110.1038/s41467‐023‐39770‐1 ↗
7. 10.1038/s41467‐018‐07815‐510.1038/s41467‐018‐07815‐5 ↗
8. 10.1038/s41590‐021‐01122‐w10.1038/s41590‐021‐01122‐w ↗
9. 10.1038/s41590‐024‐01743‐x10.1038/s41590‐024‐01743‐x ↗
10. 10.1038/s41541-025-01243-510.1038/s41541-025-01243-5 ↗
11. 10.1038/s41577‐022‐00707‐210.1038/s41577‐022‐00707‐2 ↗
12. 10.1038/s41467‐019‐11269‐810.1038/s41467‐019‐11269‐8 ↗
13. 10.1016/j.jconrel.2024.09.01810.1016/j.jconrel.2024.09.018 ↗
14. 10.1002/adma.20230767510.1002/adma.202307675 ↗
15. 10.1038/s44222‐022‐00010‐810.1038/s44222‐022‐00010‐8 ↗
16. 10.1016/j.cej.2020.12784910.1016/j.cej.2020.127849 ↗
17. 10.1021/acscentsci.7b0025710.1021/acscentsci.7b00257 ↗
18. 10.1016/j.jfutfo.2023.05.00610.1016/j.jfutfo.2023.05.006 ↗
19. 10.1038/s41565‐018‐0274‐010.1038/s41565‐018‐0274‐0 ↗
20. 10.1021/acscentsci.7b0025710.1021/acscentsci.7b00257 ↗
21. 10.1016/j.jconrel.2022.02.02710.1016/j.jconrel.2022.02.027 ↗
22. 10.1038/s41577‐024‐01079‐510.1038/s41577‐024‐01079‐5 ↗
23. 10.1038/s41580‐024‐00773‐510.1038/s41580‐024‐00773‐5 ↗
24. 10.1038/nrm351210.1038/nrm3512 ↗
25. 10.1101/gad.110270310.1101/gad.1102703 ↗
26. 10.1038/nri215210.1038/nri2152 ↗
27. 10.1016/j.devcel.2016.05.00510.1016/j.devcel.2016.05.005 ↗
28. 10.1083/jcb.20220513510.1083/jcb.202205135 ↗
29. 10.1126/sciadv.aaz446210.1126/sciadv.aaz4462 ↗
30. 10.1016/j.bioactmat.2025.08.03310.1016/j.bioactmat.2025.08.033 ↗
31. 10.1002/adma.20241262710.1002/adma.202412627 ↗
32. 10.1016/j.jconrel.2025.01.00910.1016/j.jconrel.2025.01.009 ↗
33. 10.1016/j.jconrel.2024.07.06010.1016/j.jconrel.2024.07.060 ↗
34. 10.1038/s41578‐023‐00552‐210.1038/s41578‐023‐00552‐2 ↗
35. 10.1016/j.immuni.2019.04.01110.1016/j.immuni.2019.04.011 ↗
36. 10.1038/s41586‐023‐06427‐410.1038/s41586‐023‐06427‐4 ↗
37. 10.1038/s41392‐023‐01501‐910.1038/s41392‐023‐01501‐9 ↗
38. 10.1038/s41577‐022‐00761‐w10.1038/s41577‐022‐00761‐w ↗
39. 10.1038/s41467‐021‐23683‐y10.1038/s41467‐021‐23683‐y ↗
40. 10.7554/eLife.7995710.7554/eLife.79957 ↗
41. 10.1038/s41551‐024‐01188‐510.1038/s41551‐024‐01188‐5 ↗
42. 10.1038/nature1704110.1038/nature17041 ↗
43. 10.1016/j.jconrel.2020.11.05410.1016/j.jconrel.2020.11.054 ↗
44. 10.1038/s41392‐022‐01243‐010.1038/s41392‐022‐01243‐0 ↗
45. 10.1002/advs.20241172010.1002/advs.202411720 ↗
46. 10.1021/acsnano.3c0447110.1021/acsnano.3c04471 ↗
47. 10.4110/in.2023.23.e4110.4110/in.2023.23.e41 ↗
48. 10.1038/s41577‐018‐0044‐010.1038/s41577‐018‐0044‐0 ↗
49. 10.1038/s41541-025-01069-110.1038/s41541-025-01069-1 ↗
50. 10.1038/s41577‐023‐00965‐810.1038/s41577‐023‐00965‐8 ↗
51. 10.1038/s41577‐024‐01040‐610.1038/s41577‐024‐01040‐6 ↗
52. SARS‐CoV‐2 Variant Biology: Immune Escape, Transmission and Fitness
53. 10.1038/s41577‐023‐00897‐310.1038/s41577‐023‐00897‐3 ↗
54. 10.1002/adfm.20210891710.1002/adfm.202108917 ↗
55. 10.1021/acsnano.5c0979610.1021/acsnano.5c09796 ↗
56. 10.1016/j.jconrel.2025.11428010.1016/j.jconrel.2025.114280 ↗
57. 10.26599/NR.2025.9490701010.26599/NR.2025.94907010 ↗
58. 10.1021/acsnano.4c1472810.1021/acsnano.4c14728 ↗
59. 10.1016/j.jconrel.2025.01.06910.1016/j.jconrel.2025.01.069 ↗